Max Küttner
Subscribe to Max Küttner's PostsMax Küttner focuses his practice on antitrust, competition and trade law. He has advised on numerous cross-border M&A transactions from negotiation to the notification at various national/supranational competition authorities. Read Max Küttner's full bio.
Antitrust M&A Snapshot | Q2 2024
By Glenna Siegel, Mary Hecht, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Graham Hyman and Max Küttner on Jul 25, 2024
Posted In Cartel Enforcement, DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: UNITED STATES US agencies are increasingly scrutinizing consummated mergers from years past, including Live Nation’s purchase of Ticketmaster and Meta’s acquisitions of Instagram and WhatsApp. Reports indicate that, over the past three years, companies have abandoned 37 deals in the face of Federal Trade Commission pressure. Merger activity in oil...
Continue Reading
Antitrust M&A Snapshot | Q1 2024
By Reese Poncia, Julian Rößler-Weis, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Graham Hyman and Max Küttner on May 2, 2024
Posted In Cartel Enforcement, DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: The Federal Trade Commission (FTC) and US Department of Justice have begun implementing the 2023 Merger Guidelines in their enforcement actions During a virtual workshop, the FTC highlighted its focus on private equity (PE) acquisitions of healthcare service providers and expressed concerns about PE in healthcare Artificial intelligence’s antitrust implications...
Continue Reading
Antitrust M&A Snapshot | Q4 2023
By Claire Danberg, Emilia Bonine, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Matt Evola and Max Küttner on Feb 14, 2024
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: New Merger Guidelines Released FTC Focused on Pharmaceutical Companies FTC Targets “Moat-Building” Mergers Fifth Circuit Fuels FTC’s Vertical Mergers Agenda FTC Losing Streak Reverses During the Fourth Quarter Ex post Review in the Merger Control Sphere Occurring More and More Frequently Access the full issue.
Continue Reading
Antitrust M&A Snapshot | Q2 2023
By Graham Hyman, Mary Hecht, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet, Matt Evola and Max Küttner on Jul 31, 2023
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: FTC Unveils Proposal Detailing Significant Changes to Hart-Scott-Rodino Act Merger Notifications Assa Abloy Settlement Raises Questions on Litigating the Fix and DOJ Consent Decrees Pharmaceutical Industry Remains in Regulators’ Crosshairs “Whole of Government” Competition Mandate Can Impact Deals the FTC and DOJ Do Not Challenge FTC’s Constitutionality Comes Under Fire—Again...
Continue Reading
CMA Blocks Microsoft’s Acquisition of Activision Blizzard; ‘Game Over’ for Behavioral Remedies?
By Stéphane Dionnet and Max Küttner on May 8, 2023
Posted In EC Developments, Mergers & Acquisitions
The Competition and Markets Authority (CMA) blocked what would have been the largest deal in the gaming industry to date on April 26, 2023. This decision brings attention to various significant trends, including: In dynamic markets, regulators are focusing in on whether a deal harms or could harm future competition (i.e., innovation based on predications...
Continue Reading
Antitrust M&A Snapshot | Q1 2023
By Anthony S. Ferrara, Max Küttner, Jon B. Dubrow, Joel R. Grosberg, Stéphane Dionnet and Matt Evola on Apr 20, 2023
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
Topics covered in this edition: Christine Wilson Resigns as FTC Commissioner FTC/Department of Justice Horizontal Merger Guidelines Delayed Agencies Maintain Focus on Private Equity, Especially in Healthcare Continuing a Trend: FTC Loses Challenge to Meta’s Acquisition of Within Agencies Continue to Challenge Transactions Outright Rather than Negotiate Settlements New Regulatory Burden: The EU Foreign Subsidies...
Continue Reading
European Competition Review 2022
By Jacques Buhart, Stéphane Dionnet, Frédéric Pradelles, Hendrik Viaene, Anna Ciesielska, Mary Hecht, Max Küttner, Andrea Otaola, Karolien Van der Putten and Hannelore Wiame on Feb 6, 2023
Posted In Cartel Enforcement, Consumer Protection/Privacy, EC Developments, EU Developments, Mergers & Acquisitions
This Review provides legal counsel and their teams easy reference guidance on essential EU competition law developments covering key areas of law and policy. Topics covered include: Cartels & Restrictive Agreements Abuse of Dominant Position Merger Control State Aid Legislative and Policy Developments Access the special report.
Continue Reading
Annual European Competition Review 2021
By Jacques Buhart, Hendrik Viaene, Max Küttner, Karolien Van der Putten, Frédéric Pradelles, Mary Hecht and McDermott Will & Emery on Feb 4, 2022
Posted In Brussels Developments, EC Developments, Energy/Commodities, EU Developments, French Developments, German Developments, Healthcare Antitrust, IP Antitrust, Italian Developments, Mergers & Acquisitions, Monopolization/Abuse of Dominance
In our super-connected age, we are inundated with information. It can be difficult to select what is really relevant to one’s business. The purpose of this Review is to provide legal counsel and their teams easy reference guidance on essential EU competition law developments covering key areas of law and policy, to help keep you...
Continue Reading
Antitrust M&A Snapshot | Q3 2021
By Noah Feldman Greene, Max Küttner, Jon B. Dubrow, Joel R. Grosberg and Lisa P. Rumin on Nov 1, 2021
Posted In DOJ Developments, EC Developments, EU Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions
In the United States, the US Department of Justice’s (DOJ) challenge of American Airlines and JetBlue’s “Northeast Alliance” after the joint venture’s approval by the US Department of Transportation earlier this year demonstrates the Biden administration’s commitment to aggressive antitrust enforcement. US President Joe Biden issued an Executive Order calling for tougher antitrust enforcement, including...
Continue Reading
New German Antitrust Rules: A Positive Move for Compliance Programs
By Christian Krohs and Max Küttner on Jan 22, 2021
Posted In EU Developments, German Developments
What has changed? On January 19, 2021, new German antitrust rules entered into force under the 10th amendment Act to the Act against Restraints of Competition (ARC) and introduced a number of significant changes. The Act, inter alia, revised the provisions relating to fine calculation for antitrust violations, and in doing so underlined the importance...
Continue Reading
